IS7065A - Áætlun um lyfjaskammta við meðferð og lyfjasamsetningar til getnaðarvarna í neyð - Google Patents

Áætlun um lyfjaskammta við meðferð og lyfjasamsetningar til getnaðarvarna í neyð

Info

Publication number: IS7065A
Authority: IS; Iceland
Prior art keywords: medication regimen; dose medication; emergency contraceptive; contraceptive formulations; formulations
Prior art date: 2001-11-27

Application number

IS7065A

Other languages

English (en)

Other versions

IS2691B (is

Inventor

F. A. Van Look Paul

Szabo Zsolt

Balogh Illesne

Komandi Katalin

βszlo Nemes L

Original Assignee

Richter Gedeon Vegyészeti Gy βr Rt.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-11-27

Filing date

2003-12-05

Publication date

2003-12-05

2003-12-05 Application filed by Richter Gedeon Vegyészeti Gy βr Rt. filed Critical Richter Gedeon Vegyészeti Gy βr Rt.

2003-12-05 Publication of IS7065A publication Critical patent/IS7065A/is

2010-10-15 Publication of IS2691B publication Critical patent/IS2691B/is

Links

239000003433 contraceptive agent Substances 0.000 title 1
230000002254 contraceptive effect Effects 0.000 title 1
239000003814 drug Substances 0.000 title 1
229940079593 drug Drugs 0.000 title 1
238000009472 formulation Methods 0.000 title 1
239000000203 mixture Substances 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/16—Masculine contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones

Landscapes

Health & Medical Sciences (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Endocrinology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
Epidemiology (AREA)
Diabetes (AREA)
Reproductive Health (AREA)
Gynecology & Obstetrics (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Steroid Compounds (AREA)

IS7065A 2001-11-27 2003-12-05 Áætlun um lyfjaskammta og lyfjasamsetningar til getnaðarvarnar í neyð IS2691B (is)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
HU0105173A HU227198B1 (en)	2001-11-27	2001-11-27	Pharmaceutical composition for emergency contraception containing levonorgestrel
PCT/HU2002/000129 WO2003045397A1 (en)	2001-11-27	2002-11-26	Dosage regimen and pharmaceutical composition for emergency contraception

Publications (2)

Publication Number	Publication Date
IS7065A true IS7065A (is)	2003-12-05
IS2691B IS2691B (is)	2010-10-15

Family

ID=89998939

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IS7065A IS2691B (is)	2001-11-27	2003-12-05	Áætlun um lyfjaskammta og lyfjasamsetningar til getnaðarvarnar í neyð

Country Status (33)

Country	Link
US (1)	US20050288264A2 (is)
EP (1)	EP1448207B1 (is)
JP (1)	JP2005516904A (is)
KR (1)	KR100908161B1 (is)
CN (1)	CN1551774A (is)
AP (1)	AP1849A (is)
AT (1)	ATE293978T1 (is)
AU (1)	AU2002347401A1 (is)
BR (1)	BR0210595A (is)
CA (1)	CA2450359C (is)
DE (1)	DE60203929T2 (is)
DK (1)	DK1448207T3 (is)
EA (1)	EA006545B1 (is)
EC (1)	ECSP045171A (is)
ES (1)	ES2239727T3 (is)
GE (1)	GEP20063882B (is)
HR (1)	HRP20040584B1 (is)
HU (1)	HU227198B1 (is)
IL (1)	IL159394A0 (is)
IS (1)	IS2691B (is)
MA (1)	MA27076A1 (is)
MX (1)	MXPA04005104A (is)
NO (1)	NO333984B1 (is)
NZ (1)	NZ530056A (is)
OA (1)	OA12730A (is)
PL (1)	PL206010B1 (is)
PT (1)	PT1448207E (is)
RS (1)	RS50768B (is)
SI (1)	SI1448207T1 (is)
TN (1)	TNSN04048A1 (is)
UA (1)	UA79942C2 (is)
WO (1)	WO2003045397A1 (is)
ZA (1)	ZA200404114B (is)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7867515B2 (en) *	2006-12-20	2011-01-11	TEVA Woman's Health, Inc.	Orally disintegrating solid dosage forms comprising progestin and methods of making and use thereof
AU2008341138A1 (en) *	2007-12-20	2009-07-02	Teva Women's Health, Inc.	Dosage regimens and pharmaceutical compositions and packages for emergency contraception
US8512745B2 (en)	2008-12-08	2013-08-20	Laboratoire Hra Pharma	Ulipristal acetate tablets
US9180131B2 (en)	2008-12-12	2015-11-10	Laboratoire Hra Pharma	Method for contraception
EP2419108B1 (en)	2009-04-14	2016-08-17	Laboratoire HRA Pharma	Method for on-demand contraception
MY158476A (en)	2009-06-23	2016-10-14	Bayer Ip Gmbh	Pharmaceutical composition for emergency contraception
CN101732324B (zh) *	2009-12-31	2011-12-07	广州朗圣药业有限公司	一种含有左炔诺孕酮的紧急避孕药物组合物及其制备方法
HUE029252T2 (en)	2011-06-01	2017-02-28	Estetra Sprl	Process for the preparation of intermediates of estetrol
DK2714712T3 (en)	2011-06-01	2016-12-05	Estetra Sprl	A process for the preparation of intermediates estetrol
EP2383279A1 (en)	2011-07-19	2011-11-02	Pantarhei Bioscience B.V.	Process for the preparation of estetrol
US9579329B2 (en) *	2011-08-11	2017-02-28	Estetra S.P.R.L.	Use of estetrol as emergency contraceptive
CN104797258A (zh)	2012-11-22	2015-07-22	拜耳药业股份公司	包含左炔诺孕酮和cox抑制剂的药物组合物用于按需避孕的用途和施用方法
JP6370887B2 (ja)	2013-05-23	2018-08-08	バイエル・ファルマ・アクティエンゲゼルシャフト	オンデマンド避妊のための医薬組成物およびその使用、ならびにこの医薬組成物の適用体制
CN103877058A (zh) *	2014-03-26	2014-06-25	邵娜	一种左炔诺孕酮片及其制备工艺
RS61812B1 (sr)	2015-06-18	2021-06-30	Estetra Sprl	Oralno-disperzibilna tableta koja sadrži estetriol
AU2016280863B2 (en)	2015-06-18	2021-04-01	Estetra Srl	Orodispersible dosage unit containing an estetrol component
KR102662025B1 (ko)	2015-06-18	2024-05-02	에스테트라, 소시에떼 아 레스폰서빌리떼 리미떼	에스테트롤 성분을 함유하는 구강분해성 투여 단위
MD3310346T2 (ro)	2015-06-18	2021-06-30	Estetra Sprl	Comprimată orodispersabilă ce conține estetrol
CA3178291A1 (en)	2016-08-05	2018-04-12	Estetra Srl	Method for the management of dysmenorrhea and menstrual pain
TWI801561B (zh)	2018-04-19	2023-05-11	比利時商依思特拉私人有限責任公司	化合物及其用於緩解絕經相關症狀的用途
JOP20200260A1 (ar)	2018-04-19	2019-10-19	Estetra Sprl	مركبات واستخداماتها للتخفيف من الأعراض المصاحبة لانقطاع الطمث
CN110917154A (zh) *	2019-12-12	2020-03-27	上海信谊天平药业有限公司	一种左炔诺孕酮片的制备方法
US20230338355A1 (en) *	2020-07-30	2023-10-26	Acer Therapeutics Inc.	Nk antagonists for contraception

2001
- 2001-11-27 HU HU0105173A patent/HU227198B1/hu unknown
2002
- 2002-11-26 MX MXPA04005104A patent/MXPA04005104A/es active IP Right Grant
- 2002-11-26 DE DE60203929T patent/DE60203929T2/de not_active Expired - Lifetime
- 2002-11-26 KR KR1020047002069A patent/KR100908161B1/ko active IP Right Grant
- 2002-11-26 EP EP02783334A patent/EP1448207B1/en not_active Expired - Lifetime
- 2002-11-26 WO PCT/HU2002/000129 patent/WO2003045397A1/en active IP Right Grant
- 2002-11-26 AT AT02783334T patent/ATE293978T1/de active
- 2002-11-26 RS YUP-42/04A patent/RS50768B/sr unknown
- 2002-11-26 DK DK02783334T patent/DK1448207T3/da active
- 2002-11-26 OA OA1200400148A patent/OA12730A/fr unknown
- 2002-11-26 EA EA200400731A patent/EA006545B1/ru unknown
- 2002-11-26 ES ES02783334T patent/ES2239727T3/es not_active Expired - Lifetime
- 2002-11-26 PT PT02783334T patent/PT1448207E/pt unknown
- 2002-11-26 BR BR0210595-0A patent/BR0210595A/pt not_active Application Discontinuation
- 2002-11-26 PL PL369520A patent/PL206010B1/pl unknown
- 2002-11-26 IL IL15939402A patent/IL159394A0/xx unknown
- 2002-11-26 AP APAP/P/2004/003046A patent/AP1849A/en active
- 2002-11-26 NZ NZ530056A patent/NZ530056A/en not_active IP Right Cessation
- 2002-11-26 CN CNA028137523A patent/CN1551774A/zh active Pending
- 2002-11-26 JP JP2003546899A patent/JP2005516904A/ja not_active Withdrawn
- 2002-11-26 SI SI200230132T patent/SI1448207T1/xx unknown
- 2002-11-26 GE GE5567A patent/GEP20063882B/en unknown
- 2002-11-26 AU AU2002347401A patent/AU2002347401A1/en not_active Abandoned
- 2002-11-26 CA CA2450359A patent/CA2450359C/en not_active Expired - Lifetime
- 2002-11-26 UA UA20040504015A patent/UA79942C2/uk unknown
2003
- 2003-12-05 IS IS7065A patent/IS2691B/is unknown
2004
- 2004-03-26 TN TNP2004000048A patent/TNSN04048A1/en unknown
- 2004-04-20 NO NO20041607A patent/NO333984B1/no not_active IP Right Cessation
- 2004-04-21 MA MA27643A patent/MA27076A1/fr unknown
- 2004-05-26 ZA ZA2004/04114A patent/ZA200404114B/en unknown
- 2004-06-24 HR HR20040584 patent/HRP20040584B1/xx not_active IP Right Cessation
- 2004-06-25 EC EC2004005171A patent/ECSP045171A/es unknown
- 2004-10-05 US US10/495,923 patent/US20050288264A2/en not_active Abandoned

Also Published As

Publication number	Publication date
HUP0105173D0 (en)	2002-02-28
DE60203929T2 (de)	2006-01-19
HUP0105173A3 (en)	2004-03-29
MA27076A1 (fr)	2004-12-20
PL206010B1 (pl)	2010-06-30
PT1448207E (pt)	2005-08-31
UA79942C2 (en)	2007-08-10
IL159394A0 (en)	2004-06-01
KR20040066088A (ko)	2004-07-23
RS50768B (sr)	2010-08-31
DE60203929D1 (de)	2005-06-02
EP1448207B1 (en)	2005-04-27
KR100908161B1 (ko)	2009-07-16
SI1448207T1 (en)	2005-10-31
PL369520A1 (en)	2005-04-18
WO2003045397A1 (en)	2003-06-05
CA2450359A1 (en)	2003-06-05
NO333984B1 (no)	2013-11-04
BR0210595A (pt)	2004-06-08
TNSN04048A1 (en)	2006-06-01
EP1448207A1 (en)	2004-08-25
IS2691B (is)	2010-10-15
ATE293978T1 (de)	2005-05-15
MXPA04005104A (es)	2004-08-19
ES2239727T3 (es)	2005-10-01
HRP20040584A2 (en)	2005-02-28
JP2005516904A (ja)	2005-06-09
NZ530056A (en)	2005-02-25
RS4204A (en)	2007-02-05
CN1551774A (zh)	2004-12-01
NO20041607L (no)	2004-04-20
ZA200404114B (en)	2005-10-26
DK1448207T3 (da)	2005-06-27
AP2004003046A0 (en)	2004-06-30
HU227198B1 (en)	2010-10-28
US20050288264A2 (en)	2005-12-29
ECSP045171A (es)	2004-08-27
AU2002347401A1 (en)	2003-06-10
HUP0105173A2 (hu)	2003-08-28
AP1849A (en)	2008-05-23
EA006545B1 (ru)	2006-02-24
GEP20063882B (en)	2006-07-25
OA12730A (fr)	2006-06-28
HRP20040584B1 (en)	2012-11-30
CA2450359C (en)	2011-05-10
US20050032755A1 (en)	2005-02-10
EA200400731A1 (ru)	2004-12-30

Publication	Publication Date	Title
IS7065A (is)	2003-12-05	Áætlun um lyfjaskammta við meðferð og lyfjasamsetningar til getnaðarvarna í neyð
NO20043904L (no)	2004-11-11	Oral doseringsform inneholdende en PDE4-hemmer som aktivt ingrediens og polyvinylpyrrolidon som eksipiens
ATE307571T1 (de)	2005-11-15	Pharmazeutische formulierung enthaltend bicalutamid
IS6892A (is)	2003-07-24	Lyfjasamsetningar, skammtaform og aðferðir til aðgefa epóþílon um munn
IS7076A (is)	2003-12-15	Bólusetning með einföldum skammti af Mycoplasma hyopneumoniae, og notkun efnisins í lækningaskyni
NO20033384L (no)	2003-09-25	Farmasoytisk formulering
ATE317260T1 (de)	2006-02-15	Pharmazeutische formulierungen mit platinderivaten
BRPI0209720A2 (pt)	2017-06-13	dosagem e embalagem de medicação com liberação controlada
ATE320807T1 (de)	2006-04-15	Pharmazeutische zusammensetzungen enthaltend tegaserod
NO20035627D0 (no)	2003-12-15	Farmasöytisk formulering
DK1334717T3 (da)	2008-11-24	Farmaceutiske sammensætninger til oral og topisk administrering
NO20043333L (no)	2004-09-13	Farmasoytiske parvastatinformuleringer og fremgangsmater for anvendelse av dem
ATE350016T1 (de)	2007-01-15	Bicalutamid enthaltende pharmazeutische zusammensetzung
DE60328119D1 (de)	2009-08-06	Pharmazeutische zubereitungen enthaltend modafinil
HK1064042A1 (en)	2005-01-21	Medicines and medicinal kits
ATE507831T1 (de)	2011-05-15	Melatonin enthaltende pharmazeutische formulierung
NO20026055L (no)	2003-02-24	Farmasöytiske komponenter innbefattende humant paratyreoideahormon og farmasöytiske sammenstninger for nasal administrering inneholdendekomponentene
DE10291905D2 (de)	2004-05-27	Pharmazeutische Zusammensetzung
DE60217369D1 (de)	2007-02-15	Pharmazeutische zusammensetzung enthaltend gamma-butyrobetain
DE10107261B4 (de)	2005-03-10	Pharmazeutische Zusammensetzung
DK1406591T3 (da)	2007-06-25	Farmaceutisk sammensætning til nasal tilförsel af estradiol og norethisteron
NO20041236L (no)	2004-03-24	Farmasoytisk formulering
ITMI20011390A0 (it)	2001-06-29	Formulazioni farmaceutiche per ormoni tiroidei
SE0101171D0 (sv)	2001-04-02	Pharmaceutical formulation
SE0101326D0 (sv)	2001-04-12	Pharmaceutical formulation